18-62113235-C-T
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_176787.5(PIGN):c.1333G>A(p.Val445Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000446 in 1,612,726 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_176787.5 missense
Scores
Clinical Significance
Conservation
Publications
- multiple congenital anomalies-hypotonia-seizures syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Orphanet, ClinGen, PanelApp Australia
- Fryns syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PIGN | NM_176787.5 | c.1333G>A | p.Val445Ile | missense_variant | Exon 16 of 31 | ENST00000640252.2 | NP_789744.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PIGN | ENST00000640252.2 | c.1333G>A | p.Val445Ile | missense_variant | Exon 16 of 31 | 1 | NM_176787.5 | ENSP00000492233.1 | ||
| PIGN | ENST00000400334.7 | c.1333G>A | p.Val445Ile | missense_variant | Exon 15 of 30 | 1 | ENSP00000383188.2 | |||
| PIGN | ENST00000638424.1 | n.1333G>A | non_coding_transcript_exon_variant | Exon 14 of 29 | 5 | ENSP00000491963.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152124Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000443 AC: 11AN: 248118 AF XY: 0.0000446 show subpopulations
GnomAD4 exome AF: 0.0000438 AC: 64AN: 1460484Hom.: 1 Cov.: 31 AF XY: 0.0000454 AC XY: 33AN XY: 726544 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152242Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74434 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
- -
Multiple congenital anomalies-hypotonia-seizures syndrome 1 Uncertain:1
This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 445 of the PIGN protein (p.Val445Ile). This variant is present in population databases (rs187036839, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with PIGN-related conditions. ClinVar contains an entry for this variant (Variation ID: 586226). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt PIGN protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at